Skip to Content

Incruse Ellipta

In the US, Incruse Ellipta (umeclidinium systemic) is a member of the drug class anticholinergic bronchodilators and is used to treat COPD and COPD - Maintenance.

US matches:

Ingredient matches for Incruse Ellipta


Umeclidinium Bromide is reported as an ingredient of Incruse Ellipta in the following countries:

  • Switzerland

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.